Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Sunshine Biopharma, Inc. (SBFM) had Receiveable Turnover of 2.58 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$8.90M |
|
$-1.18M |
|
$6.17M |
|
$2.73M |
|
$10.20M |
|
$-1.30M |
|
$0.08M |
|
$-1.22M |
|
$-1.22M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.18M |
|
$-1.30M |
|
$-1.23M |
|
2.70M |
|
2.70M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$24.48M |
|
$0.52M |
|
$4.71M |
|
$29.19M |
|
$5.76M |
|
-- |
|
$0.72M |
|
$6.48M |
|
$22.69M |
|
$19.51M |
|
$22.70M |
|
2.71M |
|
| Cash Flow Statement Financials | |
$-1.71M |
|
$-0.18M |
|
$0.34M |
|
$9.69M |
|
$8.12M |
|
$-1.56M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
30.67% |
|
-14.56% |
|
-14.56% |
|
-- |
|
-13.71% |
|
-13.25% |
|
$-1.72M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.52 |
|
|
Receiveable Turnover |
2.58 |
34.83 |
|
-5.20% |
|
-6.05% |
|
-4.04% |
|
-5.20% |
|
$8.38 |
|
$-0.64 |
|
$-0.63 |
|